日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Companies

Biotech boom, pride of Anhui

By Zhu Lixin (China Daily) Updated: 2016-07-19 08:14

Biotech boom, pride of Anhui

A bird's-eye view of the world's largest biotech drug production base in Hefei, Anhui province. The facility is shaped in the form of antibody ATCG. [Photo provided to China Daily]

Beijing-based Sinobioway Group Co Ltd, a major biotech company in China, is building the world's largest biotech drug production base at the Bantang township in Hefei, capital of Anhui province in East China.

The facility, shaped in the form of antibody ATCG and to be called the Bantang Bioeconomy Experimental Zone, will have 100 production lines to be completed in 10 to 15 years. The first five lines will be completed by the end of this year.

Work on another 10 will also start later this year, said Cao Wenbo, president of Anhui Sinobioway Bioeconomy Group, a subsidiary of Sinobioway Group.

The zone covers an area of 31 sq km. A 400,000-sq-meter plant is almost ready; the next two phases will take up 600,000 sq m.

Cao said infrastructure excluding the production lines will see an investment of 1.5 billion yuan ($224.3 million), which is being provided by the Hefei government.

Wu Cunrong, Party chief of Hefei city, said: "We believe the biotech drug sector will see enormous growth opportunities in future, so we will surely support such companies."

The company, Cao said, will repay the money in five years "so that we can have more money for mergers and acquisitions. We have enough money to reach the goal."

There are dozens of funds to back the ambitious project, which is expected to cost billions of yuan, he said.

"Instead of starting from the R&D stage, Sinobioway is more interested in buying drug patents and firms at home and abroad. Biotech drug production has been very profitable. But starting everything from R&D will be too time-consuming and risky. You may spend years but get nothing."

He said buying patents and firms will bring the company high profits quickly. During the process, it will also develop its own drugs.

This business model has marked the collaboration between Sinobioway and BioAlta, a San Diego-based company focused on the development of Conditionally Active Biologic antibody therapeutics.

In 2015, the two companies forged a strategic collaboration for the development and commercialization of select CAB antibodies and other CAB-based therapeutics in China. "Production of all the drugs will be based in Hefei," said Cao.

BioAlta would receive more than $70 million in payments and investment from Sinobioway in a year, according to their agreement.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 欧美视频在线观看一区 | 激情第四色 | 三级在线观看视频 | 日韩欧美中文字幕在线视频 | 成人18视频| 精品久久成人 | 国产男女av | 精品一区在线播放 | 日韩欧美在线视频观看 | 一区二区三区在线视频观看 | 天天色天天色天天色 | 中文字幕亚洲精品 | av色图 | 亚洲s色 | 高h在线观看 | 日日舔| 亚洲欧美成人综合 | 在线免费看a | 亚洲免费精品 | 玩偶姐姐在线观看免费 | 秋霞久久久| 91在线免费看 | 天堂激情网 | 黄色一区二区三区 | 他也色在线视频 | 在线观看成人免费视频 | 日韩福利网站 | 婷婷成人在线 | 日本韩国欧美 | 黄网在线免费看 | 蜜臀av中文字幕 | 性网站视频 | 五月婷婷综合激情网 | 中国一级特黄毛片 | 一区二区网 | 日本高清一二三区 | 波多野结衣久久精品 | 天天艹天天 | 成人免费看片39 | 中韩毛片| 成人福利在线观看 |